Controlled Release Camptothecin Tablets based on Pluronic and Poly(acrylic acid) Copolymer. Effect of Fabrication Technique on Drug Stability, Tablet Structure, and Release Mode

REFERENCES

• Barreiro-Iglesias R., Bromberg L., Temchenko M., Hatton T. A., Alvarez-Lorenzo C., Concheiro A. Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers. J. Control. Release 2004; 97: 537–549
   PubMed Web of Science ®Google Scholar
• Barreiro-Iglesias R., Bromberg L., Temchenko M., Hatton T. A., Alvarez-Lorenzo C., Concheiro A. Pluronic-g-poly (acrylic acid) copolymers as novel excipients for site specific, sustained release tablets. Eur. J. Pharm. Sci. 2005; 26: 374–385
   PubMed Web of Science ®Google Scholar
• Bromberg L. A novel family of thermogelling materials via C-C bonding between poly(acrylic acid) and poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide). J. Phys. Chem. B 1998a; 102: 1956–1963
   Web of Science ®Google Scholar
• Bromberg L. Polyether-modified poly(acrylic acid): synthesis and properties. Ind. Eng. Chem. Res. 1998b; 37: 4267–4274
   Web of Science ®Google Scholar
• Bromberg L. Self-assembly in aqueous solutions of polyether-modified poly(acrylic acid). Langmuir 1998c; 14: 5806–5812
   Web of Science ®Google Scholar
• Bromberg L. Properties of aqueous solutions and gels of poly(ethyleneoxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)-g-poly(acrylic acid). J. Phys. Chem. B 1998d; 102: 10736–10744
   Web of Science ®Google Scholar
• Bromberg L. Synthesis and self-assembly of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)-g-poly(acrylic acid) gels. Ind. Eng. Chem. Res. 2001; 40: 2437–2444
   Web of Science ®Google Scholar
• Bromberg L. Hydrophobically modified polyelectrolytes and polyelectrolyte block-copolymers for biomedical applications. Handbook of Polyelectrolytes and Their Applications, S. K. Tripathy, J. Kumar, H. S. Nalwa. American Scientific Publishers, New York 2002; 23–46, Chapter 51
   Google Scholar
• Bromberg L., Temchenko M. Solubilization of hydrophobic compounds by micellar solutions of hydrophobically modified polyelectrolytes. Langmuir 1999; 15: 8627–8632
   Web of Science ®Google Scholar
• Bromberg L., Temchenko M., Hatton T. A. Smart microgel studies. Polyelectrolyte and drug-absorbing properties of microgels from polyether-modified poly(acrylic acid). Langmuir 2003; 19: 8675–8684
   Web of Science ®Google Scholar
• Burke T. G., Staubus A. E., Mishra A. K. Liposomal stabilization of campothecin´s lactone ring. J. Am. Chem. Soc. 1992; 114: 8318–8319
   Web of Science ®Google Scholar
• Chan L. W., Chow K. T., Heng P. W. S. Investigation of wetting behavior of nonaqueous ethylcellulose gel matrices using dynamic contact angle. Pharm. Res 2006; 23: 408–421
   PubMed Web of Science ®Google Scholar
• Cortesi R., Esposito E., Maietti A., Menegatti E., Nastruzzi C. Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions, and a microemulsion. Int. J. Pharm. 1997; 159: 95–103
   Web of Science ®Google Scholar
• DeMario M. D., Ratain M. J. Oral chemotherapy: Rationale and future directions. J. Clin. Oncol 1998; 16: 2557–2567
   PubMed Web of Science ®Google Scholar
• Fassberg J., Stella V. J. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 1992; 81: 676–684
   PubMed Web of Science ®Google Scholar
• Fell J. T., Newton J. M. The tensile strength of lactose tablets. J. Pharm. Pharmacol. 1968; 20: 657–659
   PubMed Web of Science ®Google Scholar
• Gerrits C. J. H., deJonge M. J. A., Schellens J. H. M., Stoter G., Verweij J. Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development. Br. J. Cancer 1997; 76: 952–962
   PubMed Web of Science ®Google Scholar
• Glaberman U., Rabinowitz I., Verschraegen C. F. Alternative administration of camptothecin analogues. Expert Opin. Drug Deliv. 2005; 2: 323–333
   PubMedGoogle Scholar
• Holman L. E. The compaction behaviour of particulate materials. An elucidation based on percolation theory. Powder Technol. 1991; 66: 265–280
   Web of Science ®Google Scholar
• Huang L. L., Schwartz J. B. Studies on drug release from carbomer tablets matrix. Drug Dev. Ind. Pharm. 1995; 21: 1487–1501
   Web of Science ®Google Scholar
• Juang R. H., Storey D. Correlation of characteristics of gel extrusion module (GEM) tablet formulation and drug dissolution rate. J. Control. Release 2003; 89: 375–385
   PubMed Web of Science ®Google Scholar
• Kang J., Kumar V., Yang D., Chowdhury P. R., Hohl R. J. Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent. Eur. J. Pharm. Sci. 2002; 15: 163–170
   PubMed Web of Science ®Google Scholar
• Korsmeyer R. W., Gurny R., Doelker E., Buri P., Peppas N. A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35
   Web of Science ®Google Scholar
• Majid Khan G., Zhu J. B. Studies on drug release kinetics from ibuprofen–carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. J. Control. Release 1999; 57: 197–203
   PubMed Web of Science ®Google Scholar
• Marmur A. Kinetics of penetration into uniform porous media: testing the equivalent-capillary concept. Langmuir 2003; 19: 5956–5959
   Web of Science ®Google Scholar
• Mi Z., Burke T. G. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Biochemistry, 33: 10325–10326
   PubMed Web of Science ®Google Scholar
• Peppas N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 1985; 60: 110–111
   PubMedGoogle Scholar
• Pérez-Marcos B., Gutierrez C., Gómez-Amoza J. L., Martinez-Pacheco R., Souto C., Concheiro A. Usefulness of certain varieties of Carbomer in the formulation of hydrophilic furosemide matrices. Int. J. Pharm. 1991; 67: 113–121
   Web of Science ®Google Scholar
• Shenderova A., Burke T. G., Schwendeman S. P. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm. Res. 1999; 16: 241–248
   PubMed Web of Science ®Google Scholar
• Sparreboom A., de Jonge M. J. A., Verweij J. The use of oral cytotoxic and cytostatic drugs in cancer treatment. Eur. J. Cancer 2002; 38: 18–22
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeial Convention, Inc. United States Pharmacopoeia 27—National Formulary 22. Rockville, MD 2004
   Google Scholar
• Tong W., Wang L., D'souza M. J. Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin. Drug. Dev. Ind. Pharm. 2003; 29: 745–756
   PubMed Web of Science ®Google Scholar
• van Veen B., Pajander J., Zuurman K., Lappalainen R., Poso A., Frijlink H. W., Ketolainen J. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets. Eur. J. Pharm. Biopharm. 2005; 61: 149–157
   PubMed Web of Science ®Google Scholar
• Varma M. V. S., Kaushal A. M., Garg S. Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices. J. Control. Release 2005; 103: 499–510
   PubMed Web of Science ®Google Scholar
• Warner D. L., Burke T. G. Simple and versatile high‐performance liquid chromatographic method for the simultaneous quantification of the lactone and carboxylate forms of camptothecin anticancer drugs. J. Chromatogr. B 1997; 691: 161–171
   PubMed Web of Science ®Google Scholar
• Watanabe M., Kawano K., Yokoyama M., Opanasopit P., Okano T., Maitani Y. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int. J. Pharm. 2006; 308: 183–189
   PubMed Web of Science ®Google Scholar
• Wu S. Polymer Interface and Adhesion. Marcel Dekker, New York 1982
   Google Scholar